Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 84 EV-to-EBIT is 10.65 as of Jul. 25, 2026, which is 19% above its 10-year median of 8.98. GuruFocus rates CGSBF with a GF Score™ of 84/100 and a GF Value™ of $43.12. Among 469 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 79.32% on this metric.
Corporativo FraguaB de CV (OTCPK:CGSBF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Corporativo FraguaB de CV's Enterprise Value for the quarter that ended in Dec. 2024 was $0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Corporativo FraguaB de CV's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $232 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV EV-to-EBIT Related Terms
Corporativo FraguaB de CV EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV EV-to-EBIT Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's EV-to-EBIT falls into.
Corporativo FraguaB de CV's current Enterprise Value is $2,476 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Corporativo FraguaB de CV's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $232 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV (CGSBF) has a EV-to-EBIT of 10.65 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Corporativo FraguaB de CV and its competitors. This is 19% above median its historical median of 8.98. Over the past decade, Corporativo FraguaB de CV's EV-to-EBIT has ranged from 4.29 to 15.39. According to the industry distribution chart, Corporativo FraguaB de CV ranks #97 out of 469 companies in the Healthcare Providers & Services industry, placing it in the top 20.7%.
Is Corporativo FraguaB de CV's EV-to-EBIT too high?
Corporativo FraguaB de CV's current EV-to-EBIT of 10.65 is 19% above median its 10-year median of 8.98. Over the past 10 years, this metric has ranged from a low of 4.29 to a high of 15.39. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. Corporativo FraguaB de CV's value of 10.65 is 32.9% below this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #97 out of 469 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #97 out of 469 companies for EV-to-EBIT. This places Corporativo FraguaB de CV in the top 21% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.87. Corporativo FraguaB de CV's value of 10.65 is 32.9% below this benchmark. Historically, Corporativo FraguaB de CV's own EV-to-EBIT has ranged from 4.29 to 15.39 over the past decade. While the company's 10-year median is 8.98 vs. the industry median of 15.87, Corporativo FraguaB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current EV-to-EBIT of 10.65 is 32.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current EV-to-EBIT is 10.65, which is 19% above median its own 10-year median of 8.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current EV-to-EBIT of 10.65. The stock's GF Value™ is $43.12, compared to a current price of $29.66 — trading 31.2% below its estimated fair value. The current EV-to-EBIT is 10.65, which is 19% above median its 10-year median of 8.98 and 32.9% below the Healthcare Providers & Services industry median of 15.87. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current EV-to-EBIT is 10.65 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 31.2% below its estimated GF Value™ of $43.12.
Key valuation signals for CGSBF:
EV-to-EBIT: 10.65 (19% above median its 10-year median of 8.98)
GF Value™: $43.12 vs. price of $29.66 (31.2% below fair value)
Industry Position: 32.9% below the Healthcare Providers & Services median (#97 of 469)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for CGSBF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
